LARGO, Fla., Feb. 23, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the “Company”) announced today the results of its fiscal year 2010 third quarter which ended December 31, 2009, with revenues totaling $2,766,203 from continuing operations and a net loss basic and diluted of $(0.19) cents per share versus ($0.26) cents per share for the same period a year ago.
